No Data
No Data
No Data
No Data
No Data
Express News | JMP Securities Reiterates Market Outperform on Vigil Neuroscience, Maintains $23 Price Target
Moomoo 24/7Apr 18 13:39 ET
Vigil Neuroscience Inc: A Strong Buy on Promising ALSP Drug Trial Outcomes and Biomarker Breakthroughs
TipRanksApr 18 00:25 ET
Buy Rating Affirmed for Vigil Neuroscience on Promising Clinical Trials and Key Data Readouts
TipRanksMar 29 04:27 ET
Vigil Neuroscience Is Maintained at Buy by HC Wainwright & Co.
Vigil Neuroscience Is Maintained at Buy by HC Wainwright & Co.
Dow JonesMar 27 09:36 ET
Express News | HC Wainwright & Co. Maintains Buy on Vigil Neuroscience, Maintains $24 Price Target
Moomoo 24/7Mar 27 09:32 ET
Vigil Neuroscience Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/27/2024 724.54% HC Wainwright & Co. $24 → $24 Maintains Buy 12/19/2023 37.42% Morgan Stanley $13 → $4 D
BenzingaMar 27 09:22 ET
VinnVicious : I love IPO's going to have to check it out thank you
70523642 : fft
Blue Cat : thank you
BFarmer0718 : thanks for the heads up....definitely worth looking into.
70984079 : I will definitely check it out!
No Data
No Data